Elon hints at longevity biotech as Anthropic and OpenAI pile into AI-bio deals
acmoytoy · x · 2026-10-31
Elon Musk replied "Longevity is coming," hinting xAI may enter longevity biotech. The quoted thread maps the moves: Anthropic acquired 10-person Coefficient Bio for $400m in stock (Apr 3), OpenAI acquired Orchestra Bio and folded it into GPT-Rosalind (Oct 20), and Anthropic bought one-person AI-native biotech Mithril (Oct 27). Game theory says xAI must follow — not because Musk cares about pharma, but because biology has insatiable demand for compute. Follow the tokens.
More from Companies & People
- Foxconn deploys humanoids to assemble NVIDIA Rubin supercomputers at 99% efficiency — lukas_m_ziegler · 2026-10-31
- Databricks CEO hits back at LangChain founder: 'Databricks very much is Databricks for agents' — jefrankle · 2026-10-31
- University of Michigan open-sources its entire robotics curriculum on GitHub — lukas_m_ziegler · 2026-10-31
- Google admits AI Mode hurts Search revenue; Anthropic Ultra drops 5-hour cap; Gemini 4 Carbon tops arenas — Latent Space · 2026-10-31
- Tesla adds 124 Model Ys to Texas robotaxi fleet, +20%/week miles, P&L impact not until 2027 — mitchdeg · 2026-10-31
- Gray Area's free 'Scaling Intelligence' AI art show in SF runs through Nov 1 — charles_irl · 2026-10-31